Clinical trials
Phase 1 Movement Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 3 |
| Biogen | 1 |
| Cerevel Therapeutics, LLC | 1 |
| Denali Therapeutics Inc. | 1 |
| Michael J. Fox Foundation for Parkinson's Research | 1 |
| Neurocrine Biosciences | 1 |
| Oregon Health and Science University | 1 |
| Pfizer | 1 |
| Siena Biotech S.p.A. | 1 |
| Solid Biosciences Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Movement Disorders | 14 |
| Parkinson Disease | 8 |
| Brain Diseases | 4 |
| Central Nervous System Diseases | 4 |
| Nervous System Diseases | 4 |
| Neurodegenerative Diseases | 4 |
| Dyskinesias | 3 |
| Ataxia | 2 |
| Basal Ganglia Diseases | 2 |
| Essential Tremor | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.